GZMB and urinary bladder cancer: Strikingly, using Sweet-P, a peptide nucleic acid that specifically targets the miR-144 binding site in the 3′UTR of GRβ, Hinds’ group showed that both the expression of GRβ as well its pro-migratory effect on bladder cancer cells were significantly attenuated [15,34].